Author

Ivis Mendoza-Hernández

Observed name: Ivis Mendoza Hernández

ORCID: 0000-0002-4907-433X

Observed ORCID: 0000-0002-4907-433X

OpenAlex ID: A5059535800

Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-Plus: a double-blind, randomised, placebo-controlled phase 3 clinical trial

2022 · María Eugenia Toledo-Romaní, Mayra García-Carmenate, et al. · The Lancet Regional Health - Americas · 61

Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials

2022 · María Eugenia-Toledo-Romaní, Leslyhana Verdecia-Sánchez, et al. · Vaccine · 39

Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults

2022 · María Eugenia Toledo-Romani, Mayra García-Carmenate, et al. · Med · 29

Didactic strategy for the training of skills in clinical trials of Stomatology residents

2024 · Aliana Peña-Méndez, Ennis Ivonnet Gutiérrez, et al. · Seminars in Medical Writing and Education · 12

Safety and Efficacy of the Two Doses Conjugated Protein-Based SOBERANA-02 COVID-19 Vaccine and of a Heterologous Three-Dose Combination with SOBERANA-PLUS: Double-Blind, Randomised, Placebo-Controlled Phase 3 Clinical Trial

2022 · Maria Eugenia-Toledo-Romani, Mayra García Carmenate, et al. · SSRN Electronic Journal · 6

Safety and immunogenicity of anti-SARS CoV-2 conjugate vaccine SOBERANA 02 in a two-dose or three-dose heterologous scheme in adults: Phase IIb Clinical Trial

2022 · María Eugenia Toledo-Romani, Mayra García-Carmenate, et al. · medRxiv · 5

Nutritional Supplement Ocoxin® Combined with Gemcitabine-Based Chemotherapy in Patients with Advanced Pancreatic Adenocarcinoma

2024 · Mayté Lima-Pérez, Jorge Luis Soriano-García, et al. · Open Journal of Gastroenterology · 2

Nutritional Supplement Ocoxin® Combined with Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer

2025 · Mayté Lima-Pérez, Jorge Luis Soriano-García, et al. · International Journal of Clinical Medicine

Safety and Immunogenicity of Anti-SARS-CoV-2 Conjugate Vaccine SOBERANA 02: Phase IIb Clinical Trial

2022 · Maria Eugenia-Toledo-Romani, Mayra García Carmenate, et al. · SSRN Electronic Journal

Works count: 9

Citation count: 154

H-index: 5

I10-index: 4